These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37427852)

  • 1. Erythropoiesis-Stimulating Agents and the Risk of Vision-Threatening Diabetic Retinopathy.
    Tsui JC; Willett K; Cohen JB; Yu Y; VanderBeek BL
    Ophthalmic Epidemiol; 2024 Jun; 31(3):249-257. PubMed ID: 37427852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SGLT2 inhibitors and diabetic retinopathy progression.
    Nadelmann JB; Miller CG; McGeehan B; Yu Y; VanderBeek BL
    Graefes Arch Clin Exp Ophthalmol; 2024 Mar; 262(3):753-758. PubMed ID: 37847267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Fenofibrate Use and the Risk of Progression to Vision-Threatening Diabetic Retinopathy.
    Meer E; Bavinger JC; Yu Y; VanderBeek BL
    JAMA Ophthalmol; 2022 May; 140(5):529-532. PubMed ID: 35389455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin use and the risk of progression to vision threatening diabetic retinopathy.
    Meer E; Bavinger JC; Yu Y; Hua P; McGeehan B; VanderBeek BL
    Pharmacoepidemiol Drug Saf; 2022 Jun; 31(6):652-660. PubMed ID: 35253307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaemia and the risk of progression from non-proliferative diabetic retinopathy to vision threatening diabetic retinopathy.
    Li Y; Yu Y; VanderBeek BL
    Eye (Lond); 2020 May; 34(5):934-941. PubMed ID: 31586167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in Prevalence and Treatment of Diabetic Macular Edema and Vision-Threatening Diabetic Retinopathy Among Medicare Part B Fee-for-Service Beneficiaries.
    Lundeen EA; Andes LJ; Rein DB; Wittenborn JS; Erdem E; Gu Q; Saaddine J; Imperatore G; Chew EY
    JAMA Ophthalmol; 2022 Apr; 140(4):345-353. PubMed ID: 35238912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in the Prevalence and Treatment of Diabetic Macular Edema and Vision-Threatening Diabetic Retinopathy Among Commercially Insured Adults Aged <65 Years.
    Lundeen EA; Kim M; Rein DB; Wittenborn JS; Saaddine J; Ehrlich JR; Holliday CS
    Diabetes Care; 2023 Apr; 46(4):687-696. PubMed ID: 36637915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid-Lowering Medications Are Associated with Lower Risk of Retinopathy and Ophthalmic Interventions among United States Patients with Diabetes.
    Vail D; Callaway NF; Ludwig CA; Saroj N; Moshfeghi DM
    Am J Ophthalmol; 2019 Nov; 207():378-384. PubMed ID: 31194953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Abnormal Renal Profiles and Proliferative Diabetic Retinopathy and Diabetic Macular Edema in an Asian Population With Type 2 Diabetes.
    Hsieh YT; Tsai MJ; Tu ST; Hsieh MC
    JAMA Ophthalmol; 2018 Jan; 136(1):68-74. PubMed ID: 29167896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Intravitreous Anti-Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial.
    Maturi RK; Glassman AR; Josic K; Antoszyk AN; Blodi BA; Jampol LM; Marcus DM; Martin DF; Melia M; Salehi-Had H; Stockdale CR; Punjabi OS; Sun JK;
    JAMA Ophthalmol; 2021 Jul; 139(7):701-712. PubMed ID: 33784735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Diabetic Macular Edema and Proliferative Diabetic Retinopathy With Cardiovascular Disease: A Systematic Review and Meta-analysis.
    Xie J; Ikram MK; Cotch MF; Klein B; Varma R; Shaw JE; Klein R; Mitchell P; Lamoureux EL; Wong TY
    JAMA Ophthalmol; 2017 Jun; 135(6):586-593. PubMed ID: 28472362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Systemic Adverse Events Associated with Intravitreal Anti-VEGF Therapy for Diabetic Macular Edema in Routine Clinical Practice.
    Maloney MH; Schilz SR; Herrin J; Sangaralingham LR; Shah ND; Barkmeier AJ
    Ophthalmology; 2019 Jul; 126(7):1007-1015. PubMed ID: 30292542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Factors Associated with Vision and Edema Outcomes.
    Bressler SB; Beaulieu WT; Glassman AR; Gross JG; Melia M; Chen E; Pavlica MR; Jampol LM;
    Ophthalmology; 2018 Nov; 125(11):1776-1783. PubMed ID: 29980333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy.
    Maturi RK; Glassman AR; Josic K; Baker CW; Gerstenblith AT; Jampol LM; Meleth A; Martin DF; Melia M; Punjabi OS; Rofagha S; Salehi-Had H; Stockdale CR; Sun JK;
    JAMA; 2023 Feb; 329(5):376-385. PubMed ID: 36749332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of diabetic retinopathy on vision-specific function.
    Lamoureux EL; Tai ES; Thumboo J; Kawasaki R; Saw SM; Mitchell P; Wong TY
    Ophthalmology; 2010 Apr; 117(4):757-65. PubMed ID: 20122736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of diabetic retinopathy and diabetic macular edema on health-related quality of life in type 1 and type 2 diabetes.
    Fenwick EK; Xie J; Ratcliffe J; Pesudovs K; Finger RP; Wong TY; Lamoureux EL
    Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):677-84. PubMed ID: 22205611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is diabetic retinopathy related to subclinical cardiovascular disease?
    Kawasaki R; Cheung N; Islam FM; Klein R; Klein BE; Cotch MF; Sharrett AR; O'Leary D; Wong TY;
    Ophthalmology; 2011 May; 118(5):860-5. PubMed ID: 21168222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Diabetic Retinopathy in the US in 2021.
    Lundeen EA; Burke-Conte Z; Rein DB; Wittenborn JS; Saaddine J; Lee AY; Flaxman AD
    JAMA Ophthalmol; 2023 Aug; 141(8):747-754. PubMed ID: 37318810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between different hypoglycemic regimens and postoperative diabetic macular edema after vitrectomy in the Japanese patients with proliferative diabetic retinopathy.
    Lei C; Zhang Y; Zhang M
    Front Endocrinol (Lausanne); 2022; 13():764254. PubMed ID: 35937830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab.
    Bressler SB; Beaulieu WT; Glassman AR; Gross JG; Jampol LM; Melia M; Peters MA; Rauser ME;
    Ophthalmology; 2017 Apr; 124(4):431-439. PubMed ID: 28161147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.